Skip to main content

Table 2 The incidence of IEMs

From: Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology

No

IEMs

Incidence

Reference

1

PKU

1:14,028

0.00007128

Filed investigation

2

MSUD

1:206,667

0.00000484

[33]

4

CIT I

1: 265,700

0.00000376

[33]

5

HCY

1:212,622

0.0000047

[11]

6

MMA

1:46,500

0.00002151

[34]

7

IVA

1:265,900

0.00000376

[34]

8

GA I

1:310,200

0.00000322

[34]

9

PA

1:310,200

0.00000322

[34]

10

PCD

1:23,862

0.00004191

[35]

11

MCAD

1:372,252

0.00000269

[35]

12

VLCAD

1:620,421

0.000001611

[35]